Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB26FD1BG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,019
Award facts
- Contract value 100% obligated
- $5,019.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on October 29, 2025, by the Defense Logistics Agency for TYMLOS 80 MCG Dose Pen Injector (1.56ML) with a ceiling value of $5,019.48. This firm fixed-price delivery order, which has an ultimate completion date of October 30, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award supports the Department of Defense's pharmaceutical supply requirements and is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the DLA.
DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy that establishes multiple regional prime vendor contractors to provide comprehensive pharmaceutical products to military healthcare facilities worldwide. The company's prime contract under PPV-G GEN V, designated SPE2DR and awarded on November 13, 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group to fulfill diverse and specialized pharmaceutical requirements for Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FD1BG?
SPE2DB26FD1BG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FD1BG worth?
The government has obligated $5,019 on SPE2DB26FD1BG.
Is contract SPE2DB26FD1BG an order under another contract?
Yes. SPE2DB26FD1BG is a delivery order under SPE2DB20D9226, an indefinite delivery contract.
Was contract SPE2DB26FD1BG competed?
The extent of competition for SPE2DB26FD1BG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award